This episode tackles the issue of Botox resistance, a concern for those using neuromodulators in aesthetic medicine. Dr. Melissa K. Levin explains how antibody formation can reduce the effectiveness of treatments such as Botox over time. She discusses the importance of choosing the right type of neuromodulator and strategically planning treatment frequency to minimize resistance. Dr. Levin highlights Xeomin as having a lower likelihood of resistance compared to Botox Cosmetic or Dysport. Listeners will learn strategies for prevention and management of resistance, including switching brands or considering alternative therapies. The episode emphasizes the importance of working with a provider to explore personalized solutions while acknowledging the value of natural beauty.
Stay connected with Dr. Teri Fisher and explore the latest in AI and automation for healthcare:
🎥 Watch on YouTube for in-depth AI tutorials: YouTube.com/@DrTeriFisher
📲 Follow on Instagram for automation tips: @DrTeriFisher
💡 Discover AI tools for your practice: DrTeriFisher.com
🎙 Listen to the long-form podcast: Anti-Aging Insights
👉 Subscribe to AI Automation Minute for your daily dose of AI-powered efficiency, and share with colleagues who want to work smarter, not harder!
#AIAutomationMinute #DrTeriFisher #HealthcareAI
